Glycot Therapeutics LLC Profile last edited on: 9/6/2023
CAGE: 7FQT6
UEI: Q9DESREWJJ39
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 03
County: Howard
Congr. District: 03
County: Howard
Public Profile
Glycot Therapeutics is structured around applying the firm's innovative and proprietary chemoenzymatic platform technology for glycoengineering of glycoprotein therapeutics, including therapeutic antibodies, to improve their therapeutic efficacy.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 1742208973 | 2 | NIH | $758,303 | |
| Project Title: Development of streamlined one-pot chemoenzymatic glycan remodeling systems for antibody conjugation | ||||
| 2023 | 2 | NIH | $321,239 | |
| Project Title: Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation | ||||
| 2022 | 2 | NIH | $1,788,600 | |
| Project Title: Development of Streamlined Chemoenzymatic Glycan Remodeling Systems for Antibodies and Other Important Glycoproteins | ||||
| 2020 | 2 | NIH | $1,478,107 | |
| Project Title: Chemoenzymatic glycan remodeling of IVIG for improved anti-inflammatory activity | ||||
| 2018 | 1 | NIH | $292,823 | |
| Project Title: Chemoenzymatic Synthesis of Stable Isotope-Labeled Glycopeptides as Internal Standards for Glycosylation Quantitation | ||||
Key People / Management
Lai-Xi Wang -- Founder and President
Qiang Yang -- Founding Partner and Research Director
Guanghui Zong -- Director of Medicinal Chemistry
Qiang Yang -- Founding Partner and Research Director
Guanghui Zong -- Director of Medicinal Chemistry
Company News
There are no news available.
